US-UK Drug Deal May Result in 229,000 Extra Deaths in England, New Study Finds
The recent agreement between the UK and US on drug pricing could lead to significant health consequences in England, according to a latest analysis published in the British Medical Journal. Experts warn that millions of pounds would be diverted from essential NHS services, potentially causing tens of thousands of avoidable deaths. The study highlights the urgent need for transparency and public scrutiny of the deal’s long-term impacts.
Also Read
- Obesity No Longer Drives Higher Cardiovascular Risk in Older Adults, Global Study Finds
- Evernorth Invests $100M for AI Specialty Pharmacy Program
- Trump Administration Policies Threaten Institutionalization of People with Disabilities, Advocates Warn
- HIV-Positive Patients Face a Much Higher Risk of Anal Cancer, Study Finds

